期刊文献+

丹参和三七多种有效成分在大鼠体内的药物动力学研究 被引量:15

Pharmacokinetic Analysis of Multiple Active Components from Radix Salviae Miltiorrhizae and Radix Notoginseng in Rats Plasma
下载PDF
导出
摘要 目的建立大鼠体内丹参素、丹酚酸B、隐丹参酮、丹参酮ⅡA及三七皂苷R1、人参皂苷Rg1、人参皂苷Rb1的HPLC-ESI-MS分析方法,并用于复方丹参方的药物动力学研究。方法应用高效液相色谱三重四级杆质谱联用法测定丹参和三七多种有效成分血药浓度,以乙腈-0.1%甲酸溶液为流动相,色谱柱:Agilent C18(5μm,150 mm×4.6 mm),柱温:30℃,流速为0.5 mL.min-1。结果以电喷雾(ESI)正、负离子两种模式能有效实现丹参和三七中有效成分的分离。7种成分的峰面积与其在血样中的浓度线性关系良好(r>0.9684);平均回收率为70.09%~114.17%。7种成分均符合二室模型。结论该方法可用于复方丹参方的药物动力学研究。 Objective To develop sensitive and specific HPLC-ESI-MS methods for measurement of plasma tanshinol(TSN),salvianolic acid B(SAB),cryptotanshinone(CTS),tanshinone IIA(TSⅡA),notoginsenoside(R1),ginsenoside(Rg1),ginsenoside(Rb1) in supporting the pharmacokinetic evaluation of the compound Salvia recipes.Methods HPLC triple quadrupole mass spectrometric method was applied to determine the plasma concentration of the active Components in Radix Salviae Miltiorrhizae and Radix Notoginseng in rats plasma.Assay was performed on a reversed-phase Agilent C18(5 μm,150 mm ×4.6 mm)column with acetonitrile and 0.1 % formic acid solution as mobile phase,flow rate being 0.5 mL·min-1,and with column temperature at 30 ℃.Results The negative and positive ion ESI gave high ionization efficiency for the analytes.Provided good reproducibility for the quantification of seven components,all the compounds showed good linearity(r 〉0.9684) in the range of the test concentration,and the average recoveries of the method were between 70.09 %~121.22 %,respectively.The results indicated that seven major active components in rats could be described by a two-compartment model.Conclusion Sensitive and specific HPLC-MS methods are developed and validated,which are applicable to pharmacokinetic evaluation of compound Salvia recipes.
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2010年第6期614-618,共5页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 复方丹参方 有效成分 液相色谱-质谱联用 药物动力学 Compound Salvia recipes Active components HPLC-MS Pharmacokinetics
  • 相关文献

参考文献10

  • 1柴瑞震.丹参的药理研究近况[J].中国中医药科技,2003,10(6):390-392. 被引量:96
  • 2马珂,汤金土.三七皂甙的实验研究进展[J].浙江中西医结合杂志,2002,12(3):197-198. 被引量:82
  • 3Yu K,Ma YH,Shao Q,et al.Simultaneously determination of five ginsenosides in rabbit plasma using solid-phase extraction and HPLC/MS technique after intravenous administration of 'SHENMAl' injection[J].Pharmaceutical and Biomedical Analysis,2007,44:532-539.
  • 4Hao HP,Wang GJ,Li P,et al.Simultaneous quantification of cryp-totanshinone and its active metabolite tanshinone HA in plasma by liq-uid chromatography/tandem mass speetrometry (LC MS/MS)[J].Phar-maceutical and Biomedical Analysis,2006,40:382-388.
  • 5Pei WJ,Zhao XF,Zhu ZM,et al.Study of the determination and pharmacokinetics of Compound Danshen Dripping Pills in human serum by column switching liquid chromatography electrosprayion trap mass spectrometry[J].Chromatography B,2004,809:237-242.
  • 6Qian TX,Jiang ZH,Cai ZW.High-performance liquid chromatogra-phy coupled with tandem mass spectrometry applied for metabolic study of ginsenoside Rb1 on rat[J].Analytical Biochemistry,2006,352:87-96.
  • 7Van Breemen RB,Fitzloff JF.Electrospray Liquid-chromatography mass-spectrometry of insenosides[J].Anal Chem,1995,67:3985-3989.
  • 8Chen YF,Ine J,Ming SS,et al.Determination and pharmarokinetic analysis of salvianolic acid B in rat blood and bile by microdialysis and liquid chromatography[J].Chromatography A,2005,827:140-145.
  • 9Ji HY,Lee HW,Kim HK,et al.Simultaneous determination of ginsenoside Rbl and Rg1 in human plasma by liquid chromatography mass spectrometry[J].Pharmaceutical and Biomedical Analysis,2004,35:207-212.
  • 10Li XC,Yu CH,Cai YB,et al.Simultaneous determination of six phenolic constituents of danshen in human serum using liquid chro-matography/tandem mass spectrometry[J].Chromatography B,2005,820:41-47.

二级参考文献31

共引文献176

同被引文献173

引证文献15

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部